TORNTPHARM.NS TORRENT PHARMACEUTICALS L | INE685A01028
Financials
Trends
Details
| Breakdown | 31.03.2028 | 31.03.2027 | Change % |
|---|---|---|---|
| Total Revenue | 214.059.457.790 | 190.463.344.630 | 12.39% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | 93,95 | 68,89 | 36.38% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 24 | 24 | 0.00% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |